Institutional Equity Research for Undercovered Public Companies
Alliance Equity Research publishes independent and company-sponsored research on undercovered, emerging, and high-potential public companies globally.
Search AER-covered companies and Insights, or explore listed companies across global markets.
Latest Research
Recent initiation reports, research updates and company commentary from Alliance Equity Research.
ASML Holding N.V.
ASML
A Near-Monopoly Lithography Franchise Powering Global Semiconductor Supply Chain with EUV Dominance and High-NA Optionality
Initiation coverage examining EUV leadership, High-NA optionality, DUV economics, installed-base services, competitive moat, semiconductor demand drivers, valuation summary, and key risks.
Dexcom, Inc.
DXCM
Dominant CGM Franchise Leveraging Technology, Coverage Expansion, and Consumer Tailwinds to Sustain Multi-Year Growth
Initiation coverage examining CGM market leadership, product strategy, reimbursement expansion, recurring sensor economics, international growth, valuation summary, and key risks.
Insights
Timely analysis of company developments, industry trends, capital markets activity, and emerging investment themes across global public markets.
Industrials & AerospaceConstellium’s Recycling Gains Lift Earnings, but Higher Metal Prices Tie Up More Cash
Constellium’s higher earnings outlook reflects stronger recycling benefits and product economics despite slightly lower shipments. More expensive metal also increases working-capital requirements. Packaging and automotive sheet now drive most of the earnings improvement, making scrap costs, manufacturing efficiency and new capacity central to sustaining returns.
Technology & SemiconductorsCorning’s Optical Growth Lifts Earnings as Customer Agreements Support Its Manufacturing Expansion
Corning’s optical-connectivity business is generating faster sales growth and higher profits as AI networks expand. Long-term customer agreements support additional manufacturing capacity, but the cash benefit includes advance payments. A slower solar ramp leaves optical profitability central to funding growth and improving shareholder returns.
Biotechnology & HealthcareTango Targets First-Line Pancreatic Cancer as Larger Combination Data Support Phase 3
Tango’s larger pancreatic-cancer dataset supports further investment in its oral drug combination. A planned first-line trial would expand the clinical and commercial opportunity, while research cuts concentrate resources on PRMT5 medicines. Drug supply, dose tolerability and evidence of added benefit will determine how effectively its capital supports development.
Industrials & AerospaceINNIO’s Data-Center Deliveries Lift Margins as Customer Advances Help Fund Capacity Expansion
INNIO’s engine deliveries are turning data-center orders into higher equipment profits and potential maintenance revenue. Customer advances help fund its manufacturing expansion, although the cash comes with future delivery obligations. The raised annual outlook implies a fourth quarter close to the third-quarter revenue and adjusted EBITDA run rate.
Capital Markets & M&ALogan’s Ovintiv Deal Pairs a Montney Cash Exit With New Heavy-Oil Development
Logan shareholders would receive C$1.40 per share in cash and an interest in a new heavy-oil company. Logan Oil’s planned C$120 million financing would leave C$50 million after Woodcote’s cash purchase price, before fees and other spending. Its development capacity will depend on operating cash generation and Sawn Lake’s capital requirements.
EnergyEni’s Higher Payout Combines Stronger Operations With a Restructured Approach to Funding Growth
Eni’s higher production and refining profits support a larger shareholder payout. Outside capital also helps fund expansion and lowers reported net debt, while sharing future earnings with partners. The benefit is greater financial flexibility, with the capacity for further distributions depending on cash generation across the retained portfolio.
Biotechnology & HealthcareMacroGenics’ MGC026 Data Support Further Development, With Durability and Combination Benefits Still Unresolved
MacroGenics has evidence of MGC026 activity in heavily pretreated head-and-neck cancer, supporting further spending on a program whose global rights it retains. The planned first-line combination opens another development opportunity, but sustained responses and an acceptable safety profile are needed to strengthen its commercial and partnering prospects.
EnergySLB’s Data-Center Growth Gives Kelvion a Clearer Route to Customers and Earnings
SLB’s accelerating data-center business gives Kelvion’s cooling technologies an established route to customers. The $4.1 billion acquisition could expand revenue per project and diversify earnings, with returns depending on profitable project delivery and a $120 million annual synergy target that includes both cost savings and additional sales.
Explore Coverage
AER-covered companies combine public-company information with our proprietary research, updates, and commentary.
Find AER-Covered Companies
Explore AER-covered companies by sector, region, and market capitalization.
Research Built Around the Model
Alliance Equity Research develops written company analysis and detailed financial models together. The model is used to test operating assumptions, financial outcomes, scenarios, and valuation frameworks.
- Fundamental company analysis
- Integrated financial modeling
- Scenario-based valuation framework
- Ongoing coverage after initiation
Operating Drivers
RevenuePricingVolumeKPIsFinancial Forecast
Illustrative forecast structure, without financial values Metric FY1 FY2 FY3 FY4 Revenue Forecast output placeholder Forecast output placeholder Forecast output placeholder Forecast output placeholder EBITDA Forecast output placeholder Forecast output placeholder Forecast output placeholder Forecast output placeholder FCF Forecast output placeholder Forecast output placeholder Forecast output placeholder Forecast output placeholder Scenarios & Sensitivities
BaseUpsideDownsideValuation
DCF · Trading Multiples
Published Research
Is Your Company Undercovered?
Alliance Equity Research works with listed companies, recently listed companies, and businesses preparing to list, with a focus on undercovered, emerging, and high-potential opportunities. Our coverage includes initiation research, detailed financial modeling, and ongoing research updates.
- Initiation Research
- Financial Model
- Ongoing Updates
Investor Discovery
- AER Website
- FactSet
- LSEG Refinitiv
- AlphaSense
- Distribution Partners
Stay Current with AER
Choose the research and Insights updates you want to receive.